These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Use of cytoflavin for correction of complications of myocardial infarction]. Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE Eksp Klin Farmakol; 2002; 65(1):27-9. PubMed ID: 12025779 [TBL] [Abstract][Full Text] [Related]
6. [The use of dibunol for stimulating reparative processes in the cardiac muscle in myocardial infarct in rats]. Pichugin VV; Konorev LA; Polumiskov VIu; Karev VA Farmakol Toksikol; 1989; 52(6):52-6. PubMed ID: 2625148 [TBL] [Abstract][Full Text] [Related]
7. [Influence of kordaron, anaprilin, dimedrol and riboxin on the hemodynamic effects of strophanthin in experimental heart failure]. Gendenshteĭn EI; Lemkina SM Farmakol Toksikol; 1988; 51(2):53-6. PubMed ID: 3378606 [TBL] [Abstract][Full Text] [Related]
8. [Effect of dibunol on lipid peroxidation and the alpha-tocopherol level in the heart of rats with myocardial infarct]. Davydov BV; Golikov PP Patol Fiziol Eksp Ter; 1987; (4):69-71. PubMed ID: 3684342 [No Abstract] [Full Text] [Related]
9. [The effect of a new phenylalkyl taurine derivative on the size of the necrotic area in experimental myocardial infarct in rats]. Sapronov NS; Torkunov PA; Eliseev VV; Krylova IB; Evdokimova NR Patol Fiziol Eksp Ter; 1999; (4):19-20. PubMed ID: 10598458 [TBL] [Abstract][Full Text] [Related]
10. [Effect of riboxin on visual function in glaucoma patients (experimental clinical study)]. Iakovlev AA; Konde LA Vestn Oftalmol; 1982; (5):10-2. PubMed ID: 7147539 [No Abstract] [Full Text] [Related]
11. [The clinical efficacy and outlook for the use of new drugs for metabolic therapy in dermatology]. Kubanova AA; Khamaganova IV Vestn Dermatol Venerol; 1989; (3):57-60. PubMed ID: 2741548 [TBL] [Abstract][Full Text] [Related]
13. [Effect of riboxine on the ATPase activity and adenine nucleotide content in the myocardium in experimental myocardial infarct]. Grigor'eva MB Farmakol Toksikol; 1983; 46(4):41-3. PubMed ID: 6225679 [TBL] [Abstract][Full Text] [Related]
15. [Use of riboxin in the complex treatment of patients with acute pneumonia]. Borovkova MS; Neĭko EM Vrach Delo; 1988 Apr; (4):85-7. PubMed ID: 3400234 [No Abstract] [Full Text] [Related]
16. Effect of ethanol administration on changes in the metabolism of glycoproteins in the heart produced in isoproterenol induced myocardial infarction in rats. Remla A; Menon PV; Kurup PA Indian J Exp Biol; 1983 Nov; 21(11):623-8. PubMed ID: 6676186 [No Abstract] [Full Text] [Related]
17. [Effect of riboxin on hemodynamics and microcirculation in patients with chronic ischemic heart disease]. Bondarenko IP Vrach Delo; 1983 Jan; (1):15-8. PubMed ID: 6868490 [No Abstract] [Full Text] [Related]
18. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents]. Sernov LN; Rozonov IuB; Gatsura VV Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176 [TBL] [Abstract][Full Text] [Related]
20. Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. Chagoya de Sánchez V; Hernández-Muñoz R; López-Barrera F; Yañez L; Vidrio S; Suárez J; Cota-Garza MD; Aranda-Fraustro A; Cruz D Can J Physiol Pharmacol; 1997 Dec; 75(12):1300-11. PubMed ID: 9580216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]